| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 47.44 | 39.1% | 16.5% |
| Total Income | 47.87 | 40.3% | 17.2% |
| Expenditure | 46.28 | 37.5% | 14.9% |
| PBT | 1.59 | 243.8% | 195.9% |
| Net Profit | 1.11 | 185.5% | 166.0% |
| OPM | 6.30% | 1.52pp | 1.99pp |
| NPM | 2.32% | 1.18pp | 1.30pp |
| EPS | 0.88 | 166.7% | 131.6% |
Remi Edelstahl Tubulars Ltd: FY26 Revenue ₹141.62 Mn, PAT ₹27.43 Mn
29 May 2026 · 29 May, 7:02 pm
Summary
REMI EDELSTAHL TUBULARS LIMITED showcased a robust performance in the fourth quarter of fiscal year 2026, with Revenue from Operations growing by 16.49% to ₹4,744.05 lakhs. The company's Net Profit after Tax for Q4 FY26 soared by 186.25% year-on-year to ₹111.41 lakhs. For the full fiscal year 2026, revenue increased by 2.21% to ₹14,162.20 lakhs, and net profit after tax rose by 2.64% to ₹274.25 lakhs. Additionally, the company is strategically expanding its business by undertaking a project to manufacture Ultra High Purity tubes for the burgeoning semiconductor industry in India.
Key Highlights
- 1
Revenue from Operations for Q4 FY26 increased by 16.49% year-on-year to ₹4,744.05 lakhs, up from ₹4,072.39 lakhs in Q4 FY25.
- 2
Net Profit after Tax for the fourth quarter of FY26 saw a significant surge of 186.25% year-on-year, reaching ₹111.41 lakhs compared to ₹38.92 lakhs in the prior year's quarter.
- 3
For the full fiscal year 2026, the company reported Revenue from Operations of ₹14,162.20 lakhs, reflecting a modest 2.21% growth from ₹13,856.25 lakhs in FY25.
- 4
Annual Net Profit after Tax for FY26 grew by 2.64% to ₹274.25 lakhs, slightly up from ₹267.19 lakhs in the previous fiscal year.
- 5
Basic Earnings per Share (EPS) for Q4 FY26 was ₹0.88, while for the full FY26, it stood at ₹2.17.
- 6
The company is actively implementing a new project to manufacture Ultra High Purity (UHP) tubes, specifically designed to cater to semiconductor projects being established in India.
- 7
Shri Mahabir Prasad Shanna resigned from his position as an Independent Director due to health issues, effective June 1, 2026.
Informational and educational content only. Not investment advice.